Program areas at Amyloidosis Research Consortium
Research programs:arc has been working on a number of Research initiatives including datasharing, and patient experience studies. Arc has also developed an appointment companion tool that supports patients throughout their treatment journey. The anonymized aggregated data provides valuable real world incites. Arc is developing a patient reported outcomes tool for use in clinical practice.
Healthcare professional education:arc has carried out Research to understand the barriers and pathways to early diagnosis. From this Research, arc developed and implement targeted solutions. Arc raises awareness and provides physician education on the signs, symptoms, and care of Amyloidosis to raise the level of suspicion, improve the speed of diagnosis, and standards of care. Arc held a masterclass for physicians and nurses in dallas, tx focused on addressing the challenges of accurate diagnosis and managing care. Arc has published peer reviewed consensus guidelines defining pathway for suspicion and diagnosis with a focus on cardiology and general practice. Arc sponsored a satellite symposium at the hfsa conference on the diagnosis and treatment of cardiac Amyloidosis.
Awareness, educational programs and advocacy:arc's patient and healthcare professional programs educate physicians and tailor information to suit the patient's needs and are successfully matching them to better treatment centers, care, and clinical trials. Arc's patient advisory board are instrumental in defining and prioritizing arc's patient programs. Arc's patient support specialist provides information and guidance for patients throughout their journey. Arc also maintains a comprehensive website with the latest information and news about Amyloidosis. Arc's unique Amyloidosis pathfinder tool supports patients in finding and evaluating treatment centers and matching them with clinical trials. This tool has been further enhanced to support patients with telehealth visits and virtual care during the pandemic. Arc also hosts arc talks, a regular patient educational webinar series covering a range of important topics. Arc has developed booklets, and handouts to provide patients with in depth information on Amyloidosis related topics.
Grants made by Amyloidosis Research Consortium
Who funds Amyloidosis Research Consortium
Grants from foundations and other nonprofits
Personnel at Amyloidosis Research Consortium
Name | Title | Compensation | Date of data |
---|
Isabelle Lousada | Chief Executive Officer and Clerk | $174,102 | 2023-09-13 |
Kristen Hsu | Executive Director of Clinical Research | $125,022 | 2022-12-31 |
Vanessa Boulanger | Director of Patient Engagement | $131,888 | 2022-12-31 |
Sarah Cairns-Smith | Chair | $0 | 2022-12-31 |
Jason Shore | Treasurer | $0 | 2022-12-31 |
...and 1 more key personnel |
Financials for Amyloidosis Research Consortium
Revenues | FYE 12/2022 | FYE 12/2021 | % Change |
---|
Total grants, contributions, etc. | $2,219,649 | $1,472,339 | 50.8% |
Program services | $0 | $2,258 | -100% |
Investment income and dividends | $38,694 | $724 | 5244.5% |
Tax-exempt bond proceeds | $0 | $0 | - |
Royalty revenue | $0 | $164,964 | -100% |
Net rental income | $0 | $7,687 | -100% |
Net gain from sale of non-inventory assets | $0 | $0 | - |
Net income from fundraising events | $0 | $0 | - |
Net income from gaming activities | $0 | $0 | - |
Net income from sales of inventory | $0 | $0 | - |
Miscellaneous revenues | $1,913 | $0 | 999% |
Total revenues | $2,260,256 | $1,647,972 | 37.2% |
Organizations like Amyloidosis Research Consortium
Organization | Type | Location | Revenue |
---|
Pennington Biomedical Research Foundation (PBRF) | 501(c)(3) | Baton Rouge, LA | $4,845,894 |
Lymphatic Education and Research Network (LE&RN) | 501(c)(3) | New York, NY | $1,476,365 |
Alzheimer's Research and Prevention Foundation | 501(c)(3) | Tucson, AZ | $565,965 |
Progeria Research Foundation (PRF) | 501(c)(3) | Peabody, MA | $1,793,850 |
Tampa Va Research and Education Foundation | 501(c)(3) | Temple Terrace, FL | $3,447,053 |
Foundation for Biomedical Research (FBR) | 501(c)(3) | Washington, DC | $3,400,871 |
Atlanta Neuroscience Foundation | 501(c)(3) | Atlanta, GA | $762,909 |
Pediatric Dermatology Research Alliance | 501(c)(3) | Portland, OR | $1,402,323 |
Oklahoma Heart Hospital Research Foundation | 501(c)(3) | Oklahoma City, OK | $1,053,193 |
Metis Foundation | 501(c)(3) | San Antonio, TX | $10,187,777 |
Data update history
October 25, 2023
Posted financials
Added Form 990 for fiscal year 2022
October 25, 2023
Updated personnel
Identified 1 new personnel
October 22, 2023
Used new vendors
Identified 3 new vendors, including , , and
July 17, 2023
Posted financials
Added Form 990 for fiscal year 2021
Nonprofit Types
Grantmaking organizationsDisease research fundraisersMedical research organizationsCharities
Issues
Health
Characteristics
Conducts researchLobbyingNational levelTax deductible donationsAccepts online donations
General information
- Address
- 320 Nevada St Suite 210
- Newton, MA 02460
- Metro area
- Boston-Cambridge-Newton, MA-NH
- County
- Middlesex County, MA
- Website URL
- arci.org/Â
- Phone
- (617) 899-8810
IRS details
- EIN
- 47-2589708
- Fiscal year end
- December
- Taxreturn type
- Form 990
- Year formed
- 2015
- Eligible to receive tax-deductible contributions (Pub 78)
- Yes
Categorization
- NTEE code, primary
- H90: Medical Specialty Research
- NAICS code, primary
- 813212: Health and Disease Research Fundraising Organizations
- Parent/child status
- Independent
California AB-488 details
- AB 488 status
- May Not Operate or Solicit for Charitable Purposes
- Charity Registration status
- Delinquent
- FTB status revoked
- Not revoked
- AG Registration Number
- CT0230056
- FTB Entity ID
- None yet
- AB 488 data last updated ("as-of") date
- 2024-10-16
Free account sign-up
Want updates when Amyloidosis Research Consortium has new information, or want to find more organizations like Amyloidosis Research Consortium?
Create free Cause IQ account